Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2113-2014Class II

InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use

Biogenex Laboratories, Inc. / initiated 2014-07-01 / Terminated

Biogenex Laboratories, Inc. began a recall of InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use on . FDA classified it as Class II and gives the reason as "Product was distributed without 510(k) approval". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2113-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Biogenex Laboratories, Inc.
Product
InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use.
Product code
MVC System, Test, Her-2/Neu, Ihc
Reason for recall
Product was distributed without 510(k) approval.
FDA root cause
No Marketing Application
Action
Each customer contacted by phone - neither is in possession of the product.
Quantity in commerce
4 kits
Distribution
Brazil and Ecuador. No US distribution
Product codes and lots
Catalog number RD471-60K: Lot numbers: RD4710111, Exp Jan 2012; RD4710411, Exp. Apr 2012; RD4711013, Exp Oct 2014.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2113-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2113-2014Class IITerminatedVoluntary: Firm initiated